Why is Indegene Ltd ?
1
The company is Net-Debt Free
2
Poor long term growth as Operating profit has grown by an annual rate 7.11% of over the last 5 years
3
Flat results in Mar 26
- ROCE(HY) Lowest at 17.20%
- PAT(Q) At Rs 95.09 cr has Fallen at -13.4% (vs previous 4Q average)
- EPS(Q) Lowest at Rs 3.31
4
With ROE of 13.3, it has a Fair valuation with a 4.1 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -2.17%, its profits have risen by 2.4% ; the PEG ratio of the company is 15.4
5
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.99% over the previous quarter and collectively hold 18.56% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
6
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -2.17% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Indegene should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Indegene for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Indegene
-2.13%
-0.08
27.94%
Sensex
-3.33%
-0.25
13.43%
Quality key factors
Factor
Value
Sales Growth (5y)
16.43%
EBIT Growth (5y)
7.11%
EBIT to Interest (avg)
18.29
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
1.12
Tax Ratio
23.60%
Dividend Payout Ratio
11.78%
Pledged Shares
0
Institutional Holding
18.56%
ROCE (avg)
38.53%
ROE (avg)
14.41%
Valuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
21
Price to Book Value
4.09
EV to EBIT
23.35
EV to EBITDA
18.58
EV to Capital Employed
6.38
EV to Sales
3.28
PEG Ratio
15.36
Dividend Yield
0.37%
ROCE (Latest)
27.34%
ROE (Latest)
13.27%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
8What is working for the Company
NET SALES(Q)
Highest at Rs 1,003.40 cr
PBDIT(Q)
Highest at Rs 163.60 cr.
-5What is not working for the Company
ROCE(HY)
Lowest at 17.20%
PAT(Q)
At Rs 95.09 cr has Fallen at -13.4% (vs previous 4Q average
EPS(Q)
Lowest at Rs 3.31
Loading Valuation Snapshot...
Here's what is working for Indegene
Net Sales - Quarterly
Highest at Rs 1,003.40 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 1,003.40 cr has Grown at 23.0% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 815.68 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 163.60 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Here's what is not working for Indegene
Profit After Tax (PAT) - Quarterly
At Rs 95.09 cr has Fallen at -13.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 109.75 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 3.31
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)






